Shots:
- Eli Lilly to acquire Protomer Technologies for ~$1B, with the achievement of future development and commercial milestones
- Earlier, Lilly led an equity investment in Protomer along with JDRF T1D fund that provides Lilly with 14% ownership of promotor and is currently acquiring the remaining shares of Protomer beyond the initial investment
- The acquisition will boost Lilly’s diabetes pipeline with the addition of Protomer’s glucose-sensing insulin that can sense sugar levels in the blood and automatically activate as needed throughout the day
Click here to read full press release/ article | Ref: Lilly | Image: Wall Street Journal
The post Eli Lilly to Acquire Protomer Technologies for ~$1B first appeared on PharmaShots.
